Financings in Brief: Exogen
This article was originally published in The Gray Sheet
Executive Summary
Exogen: Going public through proposed offering of 2.5 mil. shares at an estimated $12 per share. Projected net proceeds of $27.2 mil. ($31.4 mil. if underwriters' overallotment option is fully exercised) are targeted for: development and clinicals of a mechanical stress device ($8 mil.); development and commercial introduction of expanded applications for the firm's SAFHS Sonic Accelerated Fracture Healing System and engineering enhancements to the device ($6 mil.); expansion of marketing and sales staff and efforts to obtain reimbursement for SAFHS ($4 mil.); and establishment of manufacturing capacity ($1 mil.). The offering is being underwritten by Robertson, Stephens & Company, Cowen & Company and Piper Jaffray.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.